Financial Daily from THE HINDU group of publications
Thursday, Nov 13, 2003

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Announcements


Novartis receives exclusive marketing rights for Glivec

Our Bureau

Mumbai , Nov. 12

NOVARTIS India Ltd (NIL) has become the first pharmaceutical company in India to be granted exclusive marketing rights for its oncology drug, Glivec, by the Controller General of Patents and Trademarks of India.

"The granting of the first pharma `exclusive rights' marks the beginning of a new chapter in the history of patents in India. This is a positive signal to the international community that India is progressing towards meeting all its obligations under TRIPs," Mr Ranjit Shahani, Vice-Chairman and Managing Director of the company told press persons here on Wednesday.

Describing Glivec as a breakthrough product in the treatment of cancer, he said it was one of the first oncology drugs that validate rational drug design based on an understanding of how some cancer cells work.

It is a signal transduction inhibitor, which potentially interferes with the pathways that signal the growth of tumour cells, he pointed out.

Article E-Mail :: Comment :: Syndication

Stories in this Section
Linc Pen to manufacture Mitsubishi products


No plans to set up unit in US now: Elgi
Novartis receives exclusive marketing rights for Glivec
Residency Hotel to offer service apartments
LG Pune factory to be made export hub
Handicrafts Export Corpn presents dividend cheque
Apollo Hospitals brings out CD on laparoscopic surgery
Natco to challenge grant of exclusive rights to Novartis cancer drug
Norms tightened for external borrowings — End-use conditions read tough
Corporates yet to heed RBI advice on hedging exposures
BPL to raise $100 m from external borrowing for turnaround
Natco bags award for cancer drug research
Udyog Ratna Award
RPG plans VRS for group cos; to expand retail biz
CESC VRS: `Early bird scheme evokes good response'
`HRM needs a re-look'
3 FIIs pick 4.6% promoters' stake in Pantaloon Retail
OVL to remain flagship for investments abroad
HNL staff hold picketing at Piravom Road Railway Station
Shalimar Paints in talks with 2 global majors — Plans strategic tie-ups in non-decorative coatings
Aventis scheme for osteoporosis patients
Tata Steel coal unit gets `Qimpro Benchmark'
Tata Steel banks on carbon trading to fund expansion
Metso to expand paper equipment biz in India


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line